No Data
CERo Therapeutics Presents Preclinical Data At SITC 2024 Showing CER-1236 Effectively Kills Ovarian Cancer Cells Without Toxicity In Animal Models
Compass Therapeutics Presents Biomarker Data Related To CTX-471 Clinical Activity At SITC Annual Meeting
Mural Oncology Presents Data Across Its Pipeline At 39th SITC Annual Meeting
Nektar And Collaborators Present Late-Breaking Results From Phase 2 Study Of NKTR-255 For The Treatment Of Radiation Induced Lymphopenia In Locally Advanced Non-Small Cell Lung Cancer Patients At SITC Annual Meeting; Demonstrated Statistically...
Agenus To Present Data On Botensilimab And AGEN1721 At SITC 2024; Novel Candidates Show Promise In Turning Cold And Refractory Tumors Into Responsive Targets
MiNK's INKT Cell Therapy Shows Potential For Optimal Multi-Combination For Resistant Solid Cancers At SITC 2024; PRAME-TCR INKT Overcomes Challenges From Conventional TCR-T Cells In Solid Cancers